Clinical Trial Update: Ertugliflozin and Sitagliptin Co-administration Factorial Study (VERTIS FACTORAL, MK-8835-005) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating co-administration of ertugliflozin and sitagliptin (VERTIS FACTORAL) in adults with type 2 diabetes mellitus; study completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Ertugliflozin (ertugliflozin)
• Sitagliptin (sitagliptin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2017-11-01